Valence8 US’s iShares MSCI EAFE Value ETF EFV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Sell
166,318
-111,646
-40% -$8.64M 4.24% 9
2026
Q1
$20.7M Sell
277,964
-81,709
-23% -$6.14M 7.22% 5
2025
Q4
$25.7M Buy
359,673
+5,798
+2% +$403K 7.61% 5
2025
Q3
$24M Buy
353,875
+35,048
+11% +$2.31M 8.23% 5
2025
Q2
$20.2M Sell
318,827
-98,198
-24% -$6.01M 8.52% 4
2025
Q1
$24.6M Buy
417,025
+12,777
+3% +$723K 11.52% 4
2024
Q4
$21.2M Buy
404,248
+5,062
+1% +$277K 10.19% 4
2024
Q3
$23M Hold
399,186
9.53% 4
2024
Q2
$21.2M Sell
399,186
-74,790
-16% -$4.07M 11.04% 4
2024
Q1
$25.8M Buy
473,976
+52,247
+12% +$2.73M 13.45% 4
2023
Q4
$22M Buy
421,729
+16,816
+4% +$832K 12.83% 4
2023
Q3
$19.8M Buy
404,913
+31,017
+8% +$1.54M 12.53% 3
2023
Q2
$18.3M Sell
373,896
-136,994
-27% -$6.74M 12.05% 3
2023
Q1
$24.8M Buy
+510,890
New +$24.7M 14.57% 2

Other funds holding EFV

Valence8 US's EFV Position: Q2 2026 in Review

Valence8 US reduced its iShares MSCI EAFE Value ETF (EFV) stake by 40% in Q2 2026, selling an estimated $8.64M and leaving 166,318 shares worth $12.7M. The position accounts for 4.24% of the portfolio, ranked #9.

Valence8 US first reported a position in EFV in Q1 2023 and has held it in 14 quarters since. The position peaked at $25.8M in Q1 2024. 1,245 funds tracked by Wall St. Rank hold EFV as of Q2 2026.

  • Valence8 US held 166,318 shares of iShares MSCI EAFE Value ETF worth $12.7M as of Q2 2026.
  • Valence8 US sold 111,646 iShares MSCI EAFE Value ETF shares in Q2 2026, an estimated $8.64M.
  • iShares MSCI EAFE Value ETF made up 4.24% of Valence8 US's portfolio in Q2 2026, its #9 holding.
  • Valence8 US first reported a position in iShares MSCI EAFE Value ETF in Q1 2023 and has held it in 14 quarters since.
  • Valence8 US's iShares MSCI EAFE Value ETF position peaked at $25.8M in Q1 2024.
  • 1,245 funds tracked by Wall St. Rank held iShares MSCI EAFE Value ETF as of Q2 2026.

Based on Valence8 US's 13F filing for Q2 2026, filed 6 Aug 2026.